Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
about
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease ModelingYoung at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem CellsNanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic PhenotypeInduced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discoveryCardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem CellsInduced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screeningInduced pluripotent stem cell-derived cardiomyocytes in studies of inherited arrhythmiasModelling human disease with pluripotent stem cellsClinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem CellsMaturation status of sarcomere structure and function in human iPSC-derived cardiac myocytesMultiElec: A MATLAB Based Application for MEA Data AnalysisGeneration of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cellsMutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy.Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision MedicineHuman induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypesInduced pluripotent stem cell potential in medicine, specifically focused on reproductive medicineModelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytesAntiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC ModelsStem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injuryCorrection of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy.The Effects of Pharmacological Compounds on Beat Rate Variations in Human Long QT-Syndrome CardiomyocytesThe disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients.New iPSC for old long QT syndrome modeling: putting the evidence into perspective.Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia.Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes.The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.Low extracellular potassium prolongs repolarization and evokes early afterdepolarization in human induced pluripotent stem cell-derived cardiomyocytes.A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells.Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome.Chemical genetics and its potential in cardiac stem cell therapy.Investigating human disease using stem cell models.iPCS Cell Modeling of Inherited Cardiac Arrhythmias.A near-infrared fluorescent voltage-sensitive dye allows for moderate-throughput electrophysiological analyses of human induced pluripotent stem cell-derived cardiomyocytes.Culture conditions affect cardiac differentiation potential of human pluripotent stem cells.Video image-based analysis of single human induced pluripotent stem cell derived cardiomyocyte beating dynamics using digital image correlation.N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neuronsPhysical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes.The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine.Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT SyndromeDevelopment of high content imaging methods for cell death detection in human pluripotent stem cell-derived cardiomyocytes.
P2860
Q26750618-4AEB9178-71AB-448A-B909-1CC0A5CF60AEQ26750663-FE9F2C39-0C3D-483F-A736-32EDA5B671BBQ26779454-18DAFB6D-83FF-4E7F-800B-EB943768DF2DQ26781825-33BA08EF-1631-4DAD-A588-35B3F6E5464DQ26798131-E6CBFA67-F0B3-4F8F-B1D1-B75054A67F11Q26828408-EB9ED56A-D844-48BC-B03A-96CEA7B21060Q26853227-CF23DE58-1942-46AC-B0CF-EC56EC1F9C99Q26864380-9EE36B96-ECFC-440B-99DE-F6CB27EDA0A6Q27021919-C44BE7DD-5F90-4E87-8F5B-B2D570818E18Q27024992-84B6B0EF-4B22-4706-BA12-06A939793F9EQ27304749-12EBF9A5-B1EE-4AA6-B3C6-37C133F27BBBQ27307424-BEF953EB-2C09-468A-ADB7-CE596A045C2CQ27314792-105A107D-A510-49CF-B5DC-248D0215B6A5Q28076397-CE3ADD8A-D912-43F0-A45D-CF064EDB6DAFQ28081697-3BF29FF9-7B35-4E46-B917-9C09E43EDCEBQ28083057-0E42A9E4-3BDF-4A90-9A2D-240B67CD05FCQ28255887-45F91FB8-04A5-4591-BACF-74E78FCC89CEQ28547114-A4D9881A-02C0-46AB-AB36-59B4408BBD3BQ28818235-1C706B43-1906-4C49-987A-1079FB618B82Q30411331-AFAAF848-3FD7-477F-9745-2F1F03355F2CQ30828413-532D8111-D57D-42B6-B2F2-A7433D8F19AFQ33163638-E5CD008D-DA1F-4647-B5D4-DE72C0FD41E0Q33163663-325A8B0A-CD05-496B-941F-22B28787C4C5Q33164771-8F42A83E-6D90-4FEB-8046-A7D8CDFD818BQ33704567-42FAF59C-9912-43B0-A8D9-47BEA0F90161Q33748399-E47E9830-6759-4E59-A805-DECB80B3E7FAQ33830565-EB612C5F-3915-4724-87B8-5DE70D310F19Q33961690-7C12FDE7-DF65-45B9-A3D1-1BDB6710A750Q34038853-22ED593E-3A7E-40C3-B9B0-1D2B912CE985Q34183137-65DB1151-CB5B-45D6-9DAD-4E363F9ABD6EQ34431170-3C3A2A3F-4603-4B94-85DE-209CAF799930Q34431713-56DB7692-25CB-4DEB-8F6A-C1F0DD069B45Q34439974-1BD3D373-E5DA-4FFD-A53C-ED70C7EF9010Q34465393-416A582F-63CC-4611-8EE6-90DCD4996FE1Q35141241-C652D6C8-1EE6-44F9-BA84-DB351D8B33BDQ35144310-63F68DA8-A7FC-4CF7-B079-A06F896D28EEQ35414785-DC707D35-53CA-450E-B430-2E66BD0D0AAAQ35765543-5E16E571-2478-45DD-B00C-2B8A750E85C1Q36141836-DD7B8904-CD62-49D7-B087-9DC68358702CQ36247765-BD3DD68E-8D75-4110-B835-B4B0F411A1B7
P2860
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Model for long QT syndrome typ ...... haracteristics in cell culture
@ast
Model for long QT syndrome typ ...... haracteristics in cell culture
@en
type
label
Model for long QT syndrome typ ...... haracteristics in cell culture
@ast
Model for long QT syndrome typ ...... haracteristics in cell culture
@en
prefLabel
Model for long QT syndrome typ ...... haracteristics in cell culture
@ast
Model for long QT syndrome typ ...... haracteristics in cell culture
@en
P2093
P2860
P4510
P50
P356
P1476
Model for long QT syndrome typ ...... haracteristics in cell culture
@en
P2093
Anna L Lahti
Ari-Pekka Koivisto
Bruce R Conklin
Heikki Swan
Hugh Chapman
Katriina Aalto-Setälä
Kimmo Kontula
Mari Pekkanen-Mattila
Olli Silvennoinen
Ville J Kujala
P2860
P304
P356
10.1242/DMM.008409
P577
2011-11-03T00:00:00Z